2009-11-10 02:41:01 -
Avigen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/avigen,-inc. ..
Avigen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Avigen, Inc. (Avigen) is a biopharmaceutical company engaged in the development and commercialization of small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company principally operates in the North America and is headquartered in California, the US. The company is
at the development stage. The current potential product candidate of the company is AV411, a glial attenuator.
The Avigen, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
